Skip to content

Sexual dimorphic effects of chronic phencyclidine in rats.

W D Wessinger

European Journal of Pharmacology April 13, 1995 DOI: 10.1016/0014-2999(95)00107-v (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Experimental animal study Peer reviewed
Population Male and female Sprague-Dawley rats
Intervention Phencyclidine (PCP)
Dose 10 mg/kg/day
Duration 10-day infusion
Key findings Chronic PCP infusion suppressed operant responding more in female rats (to 30-71% of control during the first 7 days) than in male rats (never below 77%), and both sexes developed tolerance by day 8 and similar abstinence effects after infusion stopped. Saturation binding studies found no significant sex differences in MK-801 receptor Kd or Bmax.

Abstract

The behavioral effects of phencyclidine (PCP) were studied in male and female Sprague-Dawley rats to determine if chronic infusions would result in sexually dimorphic effects. Rats were trained to make operant responses for food during 30-min response periods that occurred 4 times each day. After attaining stable baseline behaviors, 10 mg of PCP/kg/day was infused s.c. for 10 days. Females were more profoundly affected than males. In the females, response rates were suppressed to 30-71% of control rates during the first 7 days of infusion. In contrast, response rate in male rats never fell below 77% of control during the infusion period. By the eighth infusion day both sexes had become tolerant to these behavioral effects. After stopping infusions there was clear evidence that behavioral dependence had developed; however, the abstinence effects in males and females were similar. Saturation studies of [3H]dizocilpine (MK-801; (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine) binding to brain membranes were conducted to determine if there were sex-dependent receptor differences. There were no significant differences in Kd +/- S.D. (7.6 +/- 1.5 and 7.1 +/- 0.9 nM for males and females, respectively) or Bmax +/- S.D. (4.1 +/- 0.2 and 4.0 +/- 0.5 pmol/mg protein for males and females, respectively).

Citations in the library

Explore topics